Literature DB >> 22089529

Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis.

Young Ho Lee1, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

OBJECTIVE: The aim of this study was to determine whether interleukin-23R (IL-23R) polymorphisms confer susceptibility to ankylosing spondylitis (AS).
METHODS: The authors conducted meta-analyses on associations between IL-23R polymorphisms and AS susceptibility, using fixed and random effects models.
RESULTS: A total of 10 studies (14 separate comparisons) were included in this meta-analysis, which included European and Asian populations. Meta-analysis revealed a significant association between AS and the two alleles of rs11209032 polymorphism in all study subjects (OR = 1.182, 95% CI 1.120-1.249, P = 0.000). Stratification by ethnicity identified a significant association between this polymorphism and AS in the European (OR = 1.234, 95% CI 1.159-1.313, P = 0.000), but not in the Asian populations (OR = 1.030, 95% CI 0.921-1.152, P = 0.608). Meta-analyses of rs1004819, rs10489629, rs1343151, rs1495965, and rs2201841 polymorphisms showed the same pattern as that shown by rs11209032 meta-analysis. Meta-analysis also revealed a significant association between the two alleles of the rs11209026 and the rs11465804 polymorphisms and the risk of developing AS in Europeans. Interestingly, the rs7517847 polymorphism was found to be significantly associated with AS susceptibility in both Europeans and Asians.
CONCLUSIONS: This meta-analysis shows that the IL-23R polymorphisms are associated with the development of AS in Europeans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22089529     DOI: 10.1007/s00011-011-0398-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  31 in total

Review 1.  Genetics of ankylosing spondylitis.

Authors:  M A Brown; B P Wordsworth; J D Reveille
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

4.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

Review 5.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

6.  Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series.

Authors:  Tugce Karaderi; David Harvey; Claire Farrar; Louise H Appleton; Millicent A Stone; Roger D Sturrock; Matthew A Brown; Paul Wordsworth; Jennifer J Pointon
Journal:  Rheumatology (Oxford)       Date:  2009-02-02       Impact factor: 7.580

Review 7.  Breakthroughs in genetic studies of ankylosing spondylitis.

Authors:  M A Brown
Journal:  Rheumatology (Oxford)       Date:  2007-11-22       Impact factor: 7.580

8.  Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples.

Authors:  E Sáfrány; B Pazár; V Csöngei; L Járomi; N Polgár; C Sipeky; I F Horváth; M Zeher; G Poór; B Melegh
Journal:  Scand J Immunol       Date:  2009-07       Impact factor: 3.487

9.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  8 in total

Review 1.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

2.  Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis.

Authors:  Yu Zhai; Ke Xu; Fen Huang; Hui Peng; Chen-Chen Feng; Kao-Kao Zhu; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2012-06-21       Impact factor: 2.316

Review 3.  Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

4.  rs10865331 associated with susceptibility and disease severity of ankylosing spondylitis in a Taiwanese population.

Authors:  Ya-Feng Wen; James Cheng-Chung Wei; Yu-Wen Hsu; Hung-Yi Chiou; Henry Sung-Ching Wong; Ruey-Hong Wong; Shiro Ikegawa; Wei-Chiao Chang
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

5.  IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis.

Authors:  Sarah Fischer; Erzsébet Kövesdi; Lili Magyari; Veronika Csöngei; Kinga Hadzsiev; Béla Melegh; Péter Hegyi; Patrícia Sarlós
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

6.  Association of Interleukin-23 receptor gene polymorphisms with susceptibility to Crohn's disease: A meta-analysis.

Authors:  Wang-Dong Xu; Qi-Bing Xie; Yi Zhao; Yi Liu
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

7.  Lack of associations between two previously identified susceptible single nucleotide polymorphisms of interleukin-23 receptor gene and ankylosing spondylitis: a replication study in a Chinese Han population.

Authors:  Bang-ping Qian; Jun Jiang; Ming-liang Ji; Bin Wang; Yang Yu; Yong Qiu
Journal:  BMC Musculoskelet Disord       Date:  2013-06-17       Impact factor: 2.362

8.  Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis.

Authors:  Jacob Sode; Steffen Bank; Ulla Vogel; Paal Skytt Andersen; Signe Bek Sørensen; Anders Bo Bojesen; Malene Rohr Andersen; Ivan Brandslund; Ram Benny Dessau; Hans Jürgen Hoffmann; Bente Glintborg; Merete Lund Hetland; Henning Locht; Niels Henrik Heegaard; Vibeke Andersen
Journal:  BMC Med Genet       Date:  2018-09-12       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.